Thermo Fisher Scientific Breaks New Ground to Drive Customer Innovation and Productivity

  Thermo Fisher Scientific Breaks New Ground to Drive Customer Innovation and
  Productivity

  Unlocking Knowledge through Integrated Software, Instruments and Services

Pittcon 2013

Business Wire

PHILADELPHIA -- March 18, 2013

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, today announced that it is launching significant innovations in
software, instruments, consumables and services that unify its
industry-leading analytical instrument platforms and enable customers to turn
data into knowledge faster and more reliably.

“We’re pleased to extend our legacy of developing the most powerful analytical
tools in the industry,” said Marc N. Casper, president and chief executive
officer of Thermo Fisher Scientific. “Especially significant this year is that
we’re helping our customers to better leverage that power by launching new
software systems to make it easier for them to turn data into valuable
knowledge. By unifying instrument platforms on a single data system, we are
helping our customers to analyze information more quickly, speeding results
and accelerating the pace of discovery and applied science.”

During the annual Pittsburgh Conference and Exhibition, Thermo Fisher is
showcasing advancements in laboratory software alongside new instruments and
consumables for uses ranging from life sciences discovery to food and water
quality. The company will highlight how it fulfills its mission – to enable
its customers to make the world healthier, cleaner and safer – through the
capabilities of its three premier brands: Thermo Scientific (Booth 1835),
Fisher Scientific ^ and Unity Lab Services (Booths 1924 and 1925). Pittcon is
being held from March 17-21 at the Philadelphia Convention Center.

Turning Laboratory Data to Knowledge

Pittcon marks the global release of Thermo Scientific Chromeleon™ ver. 7.2 
software, a milestone upgrade of the gold standard in chromatography data
systems. For the first time, Chromeleon 7.2 unites mass spectrometry and
chromatography instruments. Chromeleon software now supports Thermo Scientific
mass spectrometers, including the ISQ single-quadrupole GC-MS and the TSQ-8000
GC-MS/MS. It also allows instruments to be integrated on enterprise-wide
networks, making it the ideal solution for large universities and
pharmaceutical researchers to facilitate collaboration between labs.

To further optimize laboratory assets, Thermo Fisher also introduces Unity Lab
SmartCapture Asset Utilization Monitoring for automated support, service and
maintenance, regardless of the instrument manufacturer. This new offering – a
combination of software enhancements and Unity Lab Services programs – allows
laboratory operators to determine which instruments may be under- or
over-utilized, determine optimal schedules, and plan for downtime and
servicing. In addition, the newest generation of the company’s
industry-leading LIMS platform, Thermo Scientific SampleManager LIMS™ 11 
software, offers process mapping, management and automation to improve
efficiency in computerized lab processes.

Accelerating Research and Discovery

Scientists have a growing interest in analyzing large molecules, such as
nucleic acids and proteins, as well as monoclonal antibodies and amino acids,
to unlock the potential of new techniques to diagnose and treat disease. To
enable analyses of these targets, Thermo Fisher has developed the Thermo
Scientific Dionex UltiMate™ 3000 Biocompatible Rapid Separation (BioRS) 
system, combining ultra-high performance liquid chromatography (UHPLC) with a
corrosion-resistant flow path that can withstand high salt or extreme pH
conditions typical of this type of research. The system is ideally suited to
support biopharmaceutical research, as well as quality assurance and control.

Specifically geared toward understanding therapeutic proteins, the new Thermo
Scientific Dionex GlycanPac AXH-1 HPLC column allows for better analysis of
glycans – carbohydrates that may act as potential biomarkers or as
post-translational modifications of therapeutic proteins. This improved means
of separation and analysis allows researchers to create new categories of
protein- and antibody-based therapeutics for disease.

Understanding complex biological chemicals such as dopamine and serotonin can
help biopharmaceutical researchers better understand conditions such as
Parkinson’s disease. To support this important research, the company has
unveiled the Thermo Scientific Dionex UltiMate 3000 Electrochemical Detector,
combining the speed and resolution of UHPLC with high-sensitivity,
femtogram-level electrochemical detection.

Speeding Results in Applied Markets

Increasingly strict regulatory standards for food, soil and drinking water
worldwide demand the detection of lower levels of harmful trace elements, such
as lead, mercury and chromium. To meet the need for increased sensitivity,
Thermo Fisher introduces the Thermo Scientific iCAP 7000 family of inductively
coupled plasma-optical emission spectrometers (ICP-OES) – the newest
generation of its highly successful iCAP platform. With a unique
high-resolution charged injection device (CID) imager, the platform offers
improved trace elemental analysis workflows, speed and cost with a focus on
productivity and flexibility.

The Thermo Scientific TRACE™ 1310 gas chromatograph has been enhanced with the
addition of the Thermo Scientific AI/AS 1310 Autosampler for higher throughput
of environmental samples. More than 100 samples can be loaded at a time to
enable larger industrial and contract laboratories to speed their
time-to-results while analyzing components ranging from dangerous PCBs in food
packaging to carcinogenic benzene and toluene in gasoline.

Thermo Fisher also combined software, consumables and instruments to create a
simple, turnkey pesticide analysis solution, the Thermo Scientific TSQ-8000
Pesticide Analyzer.

The Thermo Scientific PicoSpin™ 45 spectrometer – a 2012 R&D 100 Award winner
– is designed for applied analysis in laboratories of any size. The miniature
NMR spectrometer’s small footprint and lower cost also make it a good choice
for high school and college laboratories.

Continuing the trend toward easier-to-operate instruments that provide precise
results, the push-button Thermo Scientific Nicolet™ iS50  spectrometer, winner
of the Best New Analytical Instrument award at the 2012 Gulf Coast Conference,
offers advanced analytical capabilities for the non-scientist. Ideal for
analyzing polymers, rubbers, paints, foods, pharmaceuticals and forensic
evidence, the device can be upgraded from an FT-IR system to multi-range
device capable of ATR, Raman and NIR analysis without manually changing
components.

For access to all Thermo Fisher news and product photos related to Pittcon
2013, please visit our online media room at www.thermofisher.com/news.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world healthier,
cleaner and safer. With revenues of $13 billion, we have approximately 39,000
employees and serve customers within pharmaceutical and biotech companies,
hospitals and clinical diagnostic labs, universities, research institutions
and government agencies, as well as in environmental and process control
industries. We create value for our key stakeholders through three premier
brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which
offer a unique combination of innovative technologies, convenient purchasing
options and a single solution for laboratory operations management. Our
products and services help our customers solve complex analytical challenges,
improve patient diagnostics and increase laboratory productivity. Visit
www.thermofisher.com.

The following constitutes a “Safe Harbor” statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward-looking statements that involve a number of risks and uncertainties.
Important factors that could cause actual results to differ materially from
those indicated by such forward-looking statements are set forth in the
company’s Annual Report on Form 10-K for the year ended December 31, 2012,
under the caption “Risk Factors,” which is on file with the Securities and
Exchange Commission and available in the “Investors” section of our website
under the heading “SEC Filings.” Important factors that could cause actual
results to differ materially from those indicated by forward-looking
statements include risks and uncertainties relating to: the need to develop
new products and adapt to significant technological change; implementation of
strategies for improving growth; general worldwide economic conditions and
related uncertainties; dependence on customers' capital spending policies and
government funding policies; the effect of exchange rate fluctuations on
international operations; the effect of healthcare reform legislation; use and
protection of intellectual property; the effect of changes in governmental
regulations; and the effect of laws and regulations governing government
contracts, as well as the possibility that expected benefits related to the
acquisitions of PicoSpin may not materialize as expected. While we may elect
to update forward-looking statements at some point in the future, we
specifically disclaim any obligation to do so, even if estimates change and,
therefore, you should not rely on these forward-looking statements as
representing our views as of any date subsequent to today.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130318005748/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50591655&lang=en

Contact:

Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com
 
Press spacebar to pause and continue. Press esc to stop.